Kalqyl publishes analysis of Stayble Therapeutics
Stayble Therapeutics AB ("Stayble" or the "Company") has recently entered into an agreement with the analysis company Kalqyl AB ("Kalqyl") which has now published the first analysis of Stayble.In order to increase understanding of Stayble's business and the status of the Company, Kalqyl has been appointed to conduct an analysis of Stayble. In addition to presenting upcoming triggers, the analysis includes an independent review of Stayble's treatment, market potential and the competitive situation. Chronic disc-related back pain is reported to be one of the major public health problems and